We have been taking multiple initiatives to reverse this picture, such as: reducing the overall number of articles, particularly case reports, pursuing review articles and more attractive and upto-date CME, favoring publications in the scope of tropical dermatology, and being very strict regarding the articles submitted. However, we understand this alone is not enough. We need to increase our visibility, particularly towards our international peers; with this goal we need to speed up our publications with the long-awaited 132 ahead of print, expedite the review of submitted manuscripts, better qualify and standardize texts in English and refresh some design aspects of the journal. For this, we will associate with Elsevier publishing company, which will take responsibility for the graphic production, dis- This bold but necessary step does not mean we will abandon the Portuguese journal in print. But it does mean that the submission system will be in English, different from the current one, that the deadlines for authors, partners and editors will be slimmer and more disciplined, that the front page layout will change, among other international publication standards that the publisher will certainly contribute with.
ter for Capes in determining the Qualis index of journals in general. What qualifies us by Capes as a B3 journal (from A1 to B5). And, of 63 dermatology journals that were assessed/measured by the JCR, we are in the 60 th place. We cannot accept such classification. It does not do justice to Brazilian dermatology.
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